Growth Metrics

OmniAb (OABI) Change in Accured Expenses (2021 - 2026)

OmniAb (OABI) reported Change in Accured Expenses of -$2.5 million for Q1 2026, up 15.03% year-over-year from -$2.2 million in Q1 2025, and down 300.16% on a QoQ basis from $1.3 million in Q4 2025.

OmniAb (OABI) has 6 years of Change in Accured Expenses data on file, last reported at -$2.5 million in Q1 2026.

  • Quarterly Change in Accured Expenses rose 15.03% year-over-year to -$2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $215000.0 (up 111.0% YoY) and the FY2025 annual result came in at -$231000.0, up 90.41% from the prior year.
  • Change in Accured Expenses declined to -$2.5 million in Q1 2026 per OABI's latest filing, from $1.3 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $14.6 million in Q4 2022 and bottomed at -$3.4 million in Q1 2024.
  • The 5-year median for Change in Accured Expenses is $280000.0 (2025), against an average of $636764.7.
  • The widest annual swing landed in 2023, when Change in Accured Expenses soared 2257.45%; it then slumped 114.8% in 2024.
  • Tracing OABI's Change in Accured Expenses over 5 years: stood at $14.6 million in 2022, then plunged by 103.59% to -$526000.0 in 2023, then soared by 247.53% to $776000.0 in 2024, then surged by 62.37% to $1.3 million in 2025, then sank by 300.16% to -$2.5 million in 2026.
  • Per Business Quant, the three latest OABI Change in Accured Expenses figures stand at -$2.5 million (Q1 2026), $1.3 million (Q4 2025), and $280000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 931,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 70.50 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 107.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -176.03 Mn
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn -2.52 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -2.52 Mn
Mar 31, 2026 -2.52 Mn
Dec 31, 2025 1.26 Mn
Dec 31, 2025 1.26 Mn
Sep 30, 2025 280,000.00
Sep 30, 2025 280,000.00
Jun 30, 2025 1.20 Mn
Jun 30, 2025 1.20 Mn
Mar 31, 2025 -2.97 Mn
Mar 31, 2025 -2.97 Mn
Dec 31, 2024 776,000.00
Dec 31, 2024 776,000.00
Sep 30, 2024 402,000.00
Sep 30, 2024 402,000.00
Jun 30, 2024 -164,000.00
Jun 30, 2024 -164,000.00
Mar 31, 2024 -3.42 Mn
Mar 31, 2024 -3.42 Mn
Dec 31, 2023 -526,000.00
Dec 31, 2023 -526,000.00
Sep 30, 2023 2.08 Mn
Sep 30, 2023 2.08 Mn
Jun 30, 2023 1.11 Mn
Jun 30, 2023 1.11 Mn
Mar 31, 2023 -1.74 Mn
Mar 31, 2023 -1.74 Mn
Dec 31, 2022 14.64 Mn
Dec 31, 2022 14.64 Mn
Sep 30, 2022 2.18 Mn
Sep 30, 2022 2.18 Mn
Jun 30, 2022 47,000.00
Jun 30, 2022 47,000.00
Mar 31, 2022 -1.79 Mn
Mar 31, 2022 -1.79 Mn
Dec 31, 2021 1.47 Mn
Dec 31, 2021 1.47 Mn